Anzeige
Meldung des Tages: Wall Street. Trump. Antimon - ATMY steht jetzt im Zentrum politischer Macht und kritischer Versorgung
Werbung
Attraktive Knock-Outs auf Medtronic plc
Typ Hebel Bid / Ask WKN
Call
5,0 1,72 € / 1,73 €
SX4X25
Typ Hebel Bid / Ask WKN
Put
4,6 1,89 € / 1,90 €
SF8AU5
Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Alle Knock-Outs auf Medtronic plc

Medtronic Aktie News

Aktie
WKN:  A14M2J ISIN:  IE00BTN1Y115 US-Symbol:  MDT Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  Irland
102,71 $
+0,00 $
0,00%
86,938 € 01:00:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
104,95 Mrd. €
Streubesitz
11,23%
KGV
23,41
Dividende
2,83 $
Dividendenrendite
3,47%
neu: Nachhaltigkeits-Score
40 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 6,32: UJ6VVB
Werbung

Medtronic News

07.05.25 - PR Newswire
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025 PR Newswire
07.05.25 - PR Newswire
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women PR Newswire
26.04.25 - PR Newswire
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients PR Newswire
26.04.25 - PR Newswire
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-​assisted surgery system PR Newswire
25.04.25 - PR Newswire
Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results
Medtronic receives FDA approval for smallest-​diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results PR Newswire
24.04.25 - PR Newswire
Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump
Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump PR Newswire
18.04.25 - PR Newswire
New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved
New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved PR Newswire
30.03.25 - PR Newswire
Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients
Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients PR Newswire
09.03.25 - PR Newswire
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients PR Newswire
06.03.25 - PR Newswire
Medtronic announces cash dividend for fourth quarter of fiscal year 2025
Medtronic announces cash dividend for fourth quarter of fiscal year 2025 PR Newswire
24.02.25 - PR Newswire
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's PR Newswire
18.02.25 - PR Newswire
Medtronic reports third quarter fiscal 2025 financial results
Medtronic reports third quarter fiscal 2025 financial results PR Newswire
05.02.25 - PR Newswire
Medtronic to announce financial results for its third quarter of fiscal year 2025
Medtronic to announce financial results for its third quarter of fiscal year 2025 PR Newswire

Newssuche

Videos

newspaper
02.02.26 -7,76%
Technical Trading Silber Crash!
Silber Short Typ: Turbo Open End WKN: VJ4GQU Hebel: 3,77 Laufzeit: OpenEnd Einstieg: Market ... Mehr »